Pons Minano, Jose Antonio

Publications

Impact Factor

Cites

Reference	Impact Factor	Cites	Quartile
Martínez-Llordella M, Lozano JJ, Puig-Pey I, Orlando G, Tisone G, Lerut J, Benítez C, Pons JA, Parrilla P, Ramírez P, Bruguera M, Rimola A, Sánchez-Fueyo A. Using transcriptional profiling to develop a diagnostic test of operational tolerance in liver transplant recipients. J Clin Invest. 2008 Aug;118(8):2845-57. doi: 10.1172/JCI35342. PubMed PMID: 18654667; PubMed Central PMCID: PMC2483684.	11.864	255	1
Pons JA, Revilla-Nuin B, Baroja-Mazo A, Ramírez P, Martínez-Alarcón L, Sánchez-Bueno F, Robles R, Rios A, Aparicio P, Parrilla P. FoxP3 in peripheral blood is associated with operational tolerance in liver transplant patients during immunosuppression withdrawal. Transplantation. 2008 Nov 27;86(10):1370-8. doi: 10.1097/TP.0b013e318188d3e6. PubMed PMID: 19034005.	4.546	139	1
Pons JA, Yélamos J, Ramírez P, Oliver-Bonet M, Sánchez A, Rodríguez-Gago M, Navarro J, Bermejo J, Robles R, Parrilla P. Endothelial cell chimerism does not influence allograft tolerance in liver transplant patients after withdrawal of immunosuppression. Transplantation. 2003 Apr 15;75(7):1045-7. PubMed PMID: 12698096.	4.546	77	1
Pons JA, Ramírez P, Revilla-Nuin B, Pascual D, Baroja-Mazo A, Robles R, Sanchez-Bueno F, Martinez L, Parrilla P. Immunosuppression withdrawal improves long-term metabolic parameters, cardiovascular risk factors and renal function in liver transplant patients. Clin Transplant. 2009 Jun-Jul;23(3):329-36. doi: 10.1111/j.1399-0012.2008.00944.x. Epub 2009 Feb 5. PubMed PMID: 19210687.	1.665	51	3
Revilla-Nuin B, de Bejar Á, Martínez-Alarcón L, Herrero JI, Martínez-Cáceres CM, Ramírez P, Baroja-Mazo A, Pons JA. Differential profile of activated regulatory T cell subsets and microRNAs in tolerant liver transplant recipients. Liver Transpl. 2017 Jul;23(7):933-945. doi: 10.1002/lt.24691. PubMed PMID: 28006867.	4.57	22	1
Baroja-Mazo A, Revilla-Nuin B, Parrilla P, Martínez-Alarcón L, Ramírez P, Pons JA. Tolerance in liver transplantation: Biomarkers and clinical relevance. World J Gastroenterol. 2016 Sep 14;22(34):7676-91. doi: 10.3748/wjg.v22.i34.7676. Review. PubMed PMID: 27678350; PubMed Central PMCID: PMC5016367.	3.665	22	2
Baroja-Mazo A, Revilla-Nuin B, de Bejar Á, Martínez-Alarcón L, Herrero JI, El-Tayeb A, Müller CE, Aparicio P, Pelegrín P, Pons JA. Extracellular adenosine reversibly inhibits the activation of human regulatory T cells and negatively influences the achievement of the operational tolerance in liver transplantation. Am J Transplant. 2019 Jan;19(1):48-61. doi: 10.1111/ajt.15023. Epub 2018 Aug 31. PubMed PMID: 30019408; PubMed Central PMCID: PMC6298591.	7.338	18	1
Pérez-Sanz F, Revilla-Nuin B, Martínez-Alarcón L, Herrero JI, Ramírez P, Pons JA, Baroja-Mazo A. Tolerance Biomarkers in Liver Transplantation: Independent External Validation of the Predictive Strength of SENP6 and FEM1C Gene Expression. Transplantation. 2019 Sep;103(9):1887-1892. doi: 10.1097/TP.0000000000002587. PubMed PMID: 30720688.	4.546	12	1
Pons JA, Revilla-Nuin B, Ramírez P, Baroja-Mazo A, Parrilla P. [Development of immune tolerance in liver transplantation]. Gastroenterol Hepatol. 2011 Mar;34(3):155-69. doi: 10.1016/j.gastrohep.2010.11.007. Epub 2011 Mar 3. Review. Spanish. PubMed PMID: 21376423.	1.581	11	4
Pons JA, Revilla Nuin B, Ramírez P, Baroja Mazo A, Martínez Alarcón L, Robles R, Sánchez Bueno F, Rios A, Cascales Campos P, Parrilla P. What do we know about the clinical impact of complete withdrawal of immunosuppression in liver transplantation? Transplant Proc. 2012 Jul-Aug;44(6):1530-2. doi: 10.1016/j.transproceed.2012.05.026. Review. PubMed PMID: 22841204.	0.784	6	4
Pons Miñano JA. [Operational tolerance in liver transplantation is more frequent than expected and increases with time after the intervention]. Gastroenterol Hepatol. 2013 Nov;36(9):551-4. doi: 10.1016/j.gastrohep.2013.07.001. Epub 2013 Sep 9. Spanish. PubMed PMID: 24029172.	1.581	1	4

Reference

Impact Factor

Cites

Quartile

Martínez-Llordella M, Lozano JJ, Puig-Pey I, Orlando G, Tisone G, Lerut J, Benítez C, Pons JA, Parrilla P, Ramírez P, Bruguera M, Rimola A, Sánchez-Fueyo A. Using transcriptional profiling to develop a diagnostic test of operational tolerance in liver transplant recipients. J Clin Invest. 2008 Aug;118(8):2845-57. doi: 10.1172/JCI35342. PubMed PMID: 18654667; PubMed Central PMCID: PMC2483684.

11.864

255

Pons JA, Revilla-Nuin B, Baroja-Mazo A, Ramírez P, Martínez-Alarcón L, Sánchez-Bueno F, Robles R, Rios A, Aparicio P, Parrilla P. FoxP3 in peripheral blood is associated with operational tolerance in liver transplant patients during immunosuppression withdrawal. Transplantation. 2008 Nov 27;86(10):1370-8. doi: 10.1097/TP.0b013e318188d3e6. PubMed PMID: 19034005.

4.546

139

Pons JA, Yélamos J, Ramírez P, Oliver-Bonet M, Sánchez A, Rodríguez-Gago M, Navarro J, Bermejo J, Robles R, Parrilla P. Endothelial cell chimerism does not influence allograft tolerance in liver transplant patients after withdrawal of immunosuppression. Transplantation. 2003 Apr 15;75(7):1045-7. PubMed PMID: 12698096.

4.546

Pons JA, Ramírez P, Revilla-Nuin B, Pascual D, Baroja-Mazo A, Robles R, Sanchez-Bueno F, Martinez L, Parrilla P. Immunosuppression withdrawal improves long-term metabolic parameters, cardiovascular risk factors and renal function in liver transplant patients. Clin Transplant. 2009 Jun-Jul;23(3):329-36. doi: 10.1111/j.1399-0012.2008.00944.x. Epub 2009 Feb 5. PubMed PMID: 19210687.

1.665

Revilla-Nuin B, de Bejar Á, Martínez-Alarcón L, Herrero JI, Martínez-Cáceres CM, Ramírez P, Baroja-Mazo A, Pons JA. Differential profile of activated regulatory T cell subsets and microRNAs in tolerant liver transplant recipients. Liver Transpl. 2017 Jul;23(7):933-945. doi: 10.1002/lt.24691. PubMed PMID: 28006867.

4.57

Baroja-Mazo A, Revilla-Nuin B, Parrilla P, Martínez-Alarcón L, Ramírez P, Pons JA. Tolerance in liver transplantation: Biomarkers and clinical relevance. World J Gastroenterol. 2016 Sep 14;22(34):7676-91. doi: 10.3748/wjg.v22.i34.7676. Review. PubMed PMID: 27678350; PubMed Central PMCID: PMC5016367.

3.665

Baroja-Mazo A, Revilla-Nuin B, de Bejar Á, Martínez-Alarcón L, Herrero JI, El-Tayeb A, Müller CE, Aparicio P, Pelegrín P, Pons JA. Extracellular adenosine reversibly inhibits the activation of human regulatory T cells and negatively influences the achievement of the operational tolerance in liver transplantation. Am J Transplant. 2019 Jan;19(1):48-61. doi: 10.1111/ajt.15023. Epub 2018 Aug 31. PubMed PMID: 30019408; PubMed Central PMCID: PMC6298591.

7.338

Pérez-Sanz F, Revilla-Nuin B, Martínez-Alarcón L, Herrero JI, Ramírez P, Pons JA, Baroja-Mazo A. Tolerance Biomarkers in Liver Transplantation: Independent External Validation of the Predictive Strength of SENP6 and FEM1C Gene Expression. Transplantation. 2019 Sep;103(9):1887-1892. doi: 10.1097/TP.0000000000002587. PubMed PMID: 30720688.

4.546

Pons JA, Revilla-Nuin B, Ramírez P, Baroja-Mazo A, Parrilla P. [Development of immune tolerance in liver transplantation]. Gastroenterol Hepatol. 2011 Mar;34(3):155-69. doi: 10.1016/j.gastrohep.2010.11.007. Epub 2011 Mar 3. Review. Spanish. PubMed PMID: 21376423.

1.581

Pons JA, Revilla Nuin B, Ramírez P, Baroja Mazo A, Martínez Alarcón L, Robles R, Sánchez Bueno F, Rios A, Cascales Campos P, Parrilla P. What do we know about the clinical impact of complete withdrawal of immunosuppression in liver transplantation? Transplant Proc. 2012 Jul-Aug;44(6):1530-2. doi: 10.1016/j.transproceed.2012.05.026. Review. PubMed PMID: 22841204.

0.784

Pons Miñano JA. [Operational tolerance in liver transplantation is more frequent than expected and increases with time after the intervention]. Gastroenterol Hepatol. 2013 Nov;36(9):551-4. doi: 10.1016/j.gastrohep.2013.07.001. Epub 2013 Sep 9. Spanish. PubMed PMID: 24029172.

1.581

Address

Biomedical Informatics & Bioinformatics Platform
Institute for Bio-health Research of Murcia (IMIB-Arrixaca)
Carretera Buenavista s/n, 30120
El Palmar, Murcia, Spain